Cimetidine impairs clearance of antipyrine and desmethyldiazepam in the elderly.
Sixteen young (21-40 years) and nine elderly (65-78 years) volunteers received single intravenous doses of antipyrine on two occasions: once in the control state, and again while receiving therapeutic doses of cimetidine (300 mg every six hours). In the control state, antipyrine half-life was longer in elderly than in young subjects (16.4 vs 11.0 hours), and metabolic clearance lower (0.48 vs 0.72 ml/min/kg). However, coadministration of cimetidine prolonged antipyrine half-life to a similar extent in elderly and in young groups (150 and 153 per cent of control) and reduced metabolic clearance to a similar extent in both (79 vs 69 per cent of control) groups. Three young and six elderly volunteers received a single 15 mg oral dose of clorazepate, a precursor of desmethyldiazepam, with and without cimetidine. As in the case of antipyrine, cimetidine prolonged desmethyldiazepam half-life similarly in young and elderly groups (175 vs 164 per cent of control) and similarly reduced metabolic clearance (51 vs 65 per cent of control). The elderly population may already have an impaired capacity to oxidize drugs. This capacity is further impaired by coadministration of cimetidine.
D000328:Adult; D000368:Aged; D000983:Antipyrine / Q000008:administration & dosage / Q000378:metabolism; D002927:Cimetidine / Q000008:administration & dosage / Q000494:pharmacology*; D003009:Clorazepate Dipotassium / Q000008:administration & dosage / Q000378:metabolism; D006146:Guanidines / Q000494:pharmacology*; D006801:Humans; D008657:Metabolic Clearance Rate / Q000187:drug effects*; D008875:Middle Aged; D003708:Nordazepam / Q000008:administration & dosage / Q000378:metabolism
D006146:Guanidines; D003009:Clorazepate Dipotassium; D003708:Nordazepam; D002927:Cimetidine; D000983:Antipyrine